3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione has been researched along with Fibromyalgia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, RL; Bruck, SM; Caumo, W; da Silveira Alves, CF; de Oliveira Franco, Á; de Oliveira Venturini, G; Fregni, F; Ramalho, L; Tomedi, R; Torres, ILS; Vicuña, P | 1 |
1 other study(ies) available for 3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione and Fibromyalgia
| Article | Year |
|---|---|
Functional connectivity response to acute pain assessed by fNIRS is associated with BDNF genotype in fibromyalgia: an exploratory study.
Topics: Acute Pain; Adolescent; Adult; Aged; Brain-Derived Neurotrophic Factor; Female; Fibromyalgia; Genotype; Humans; Middle Aged; Polymorphism, Single Nucleotide; Quality of Life; Young Adult | 2022 |